Researchers at the University of Nebraska Medical Center studied 6.14 million U.S. births and found that mothers prescribed medications that disrupt cholesterol synthesis during pregnancy—including common antidepressants, antipsychotics, statins, and beta-blockers—had children with higher autism rates. The finding matters because cholesterol is essential for fetal brain development, and even small disruptions during key windows may affect neurodevelopment; however, the study's authors explicitly state these medications are often life-saving and pregnant patients should not stop them without medical supervision. The research calls for re-evaluating prescribing practices and developing safer alternatives for pregnancy, not for banning these drugs. One limitation: the study identifies association, not proven causation—confounding factors like maternal age, disease severity, and socioeconomic status (which influence both medication use and autism diagnosis rates) may play a role that the research partially but may not fully account for.